Health Essentials (India) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -44.45%
- Profit Growth -116.08%
- Ebitda 147.90%
- Net Worth -32.77%
- Total Assets -74.17%
About Health Essentials (India)
Health Essentials (India) Private Limited (HEIPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 May 2015 (Nine years and eight months 19 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Giridhara Mungi and Laxman Prasad serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900TG2015PTC098936
-
Company No.
098936
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 May 2015
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Health Essentials (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Giridhara Mungi
|
Director | 14-Dec-2020 | Current |
|
Laxman Prasad
|
Director | 15-May-2015 | Current |
Financial Performance of Health Essentials (India).
Health Essentials (India) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 44.45% decrease. The company also saw a substantial fall in profitability, with a 116.08% decrease in profit. The company's net worth observed a substantial decline by a decrease of 32.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Health Essentials (India)?
In 2019, Health Essentials (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bion Therapeutics (India) Private LimitedGiridhara Mungi and Laxman Prasad are mutual person
-
Biondia Therapeutics Private LimitedLaxman Prasad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Health Essentials (India)?
Unlock and access historical data on people associated with Health Essentials (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Health Essentials (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Health Essentials (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
